ROCKET PHARMACEUTICALS, INC. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Rocket Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2025.
  • Rocket Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2025 was $364K, a 9.31% increase year-over-year.
  • Rocket Pharmaceuticals, Inc. annual Operating Lease, Payments for 2024 was $1.16M, a 29.4% increase from 2023.
  • Rocket Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $894K, a 4.69% decline from 2022.
  • Rocket Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $938K, a 43.2% increase from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $364K +$31K +9.31% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2024 $333K +$72K +27.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2023 $261K +$32K +14% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $229K +$3K +1.33% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q1 2021 $226K -$114K -33.5% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-10
Q1 2020 $340K +$70K +25.9% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-08
Q1 2019 $270K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.